The Hyderabad-based CRDMO is betting on its recently announced capacity expansion for biologics and high-demand antibody drug conjugates, or ADCs, to leverage the shift.
Recent Posts
- Did this recently-listed smallcap stock really crash 90% in one day? Here’s why you should ignore the plunge
- Mehul Telecom share price makes a strong debut, stock opens with a 10.20% premium at ₹108 apiece on BSE SME
- Rajesh Palviya of Axis Sec suggests Glenmark Pharma, Marico, SAIL shares to buy on 24 April
- Crude oil price today in India trades flat despite escalation in the US-Iran war
- Infosys share price falls 3.5% to 52-week low post Q4 results on weak FY27 guidance – What are brokerages saying?